Efficacy and safety of CAR-T cell therapy in minorities

Bone Marrow Transplant. 2022 Jul;57(7):1187-1190. doi: 10.1038/s41409-022-01670-1. Epub 2022 Apr 28.

Authors

Affiliations

¹ Department of Oncology, Montefiore Einstein Cancer Center, Blood Cancer Institute, Montefiore Medical Center, Bronx, New York, NY, USA.
² Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, NY, USA.
³ Montefiore Health System, Bronx, New York, NY, USA.
⁴ Department of Oncology, Montefiore Einstein Cancer Center, Blood Cancer Institute, Montefiore Medical Center, Bronx, New York, NY, USA. ibraunsc@montefiore.org.
⁵ Department of Oncology, Montefiore Einstein Cancer Center, Blood Cancer Institute, Montefiore Medical Center, Bronx, New York, NY, USA. mgoldfin@montefiore.org.

^# Contributed equally.

PMID: 35484206
DOI: 10.1038/s41409-022-01670-1

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Cell- and Tissue-Based Therapy
Humans
Immunotherapy, Adoptive / adverse effects
Receptors, Antigen, T-Cell
Receptors, Chimeric Antigen* / therapeutic use

Substances

Receptors, Antigen, T-Cell
Receptors, Chimeric Antigen